ondansetron has been researched along with Acute Edematous Pancreatitis in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberti-Flor, JJ | 1 |
| Granados, LM | 1 |
| Ballester, F | 1 |
| Suárez, F | 1 |
| Sánchez-Peña, J | 1 |
| Navas, E | 1 |
2 other studies available for ondansetron and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Pancreatitis associated with ondansetron.
Topics: Humans; Male; Middle Aged; Ondansetron; Pancreatitis | 1995 |
[Acute postoperative pancreatitis, is it associated with the use of ondansetron?].
Topics: Acute Disease; Adolescent; Antiemetics; Humans; Nasal Bone; Ondansetron; Pancreatitis; Postoperative | 1997 |